NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-036-2015-0-US-01 NK Cells with an Increased Antibody-Dependent Cellular Toxicity (ADCC) Against Tumors US 62/079,975 Abandoned
NIAID E-278-2016-0-US-01 Antibodies That Neutralize Ebola Virus And Uses Thereof US 62/080,094 Abandoned
NCI E-226-2014-0-US-01 Anti-Human Thyroglobulin T Cell Receptors US 62/079,713 Abandoned
NCI E-256-2008-0-US-06 Survival Predictor for Diffuse Large B Cell Lymphoma US CON 14/540,302 9970059 Issued PDF
NHLBI E-516-2013-0-PCT-02 DETECTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK AND MYOCARDIAL INFARCTION RISK PCT PCT PCT/US2014/065527 Expired
NHLBI E-515-2013-0-PCT-02 DETECTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK AND HEART FAILURE RISK PCT PCT PCT/US2014/065524 Expired
NCI E-273-2011-0-US-03 Cross-Reactive Antibodies Against Dengue Virus And Uses Thereof US National Stage 14/400,642 9556254 Abandoned PDF
NICHD E-039-2016-0-US-01 METHOD FOR TREATMENT OF HORMONAL DISORDERS OF GROWTH USING ANTAGONlSTS AND AGONISTS OF THE ORPHAN G-PROTEIN COUPLED RECEPTOR {GPCR), GPR101 US 62/078,517 Abandoned
NCI E-040-2012-0-KR-16 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen KR National Stage 2014-7031520 Issued
CC E-149-2014-0-US-01 Topical Sodium Nitrate Formulation US 62/077,622 Abandoned
NIAID E-152-2015-0-US-01 Probiotic Therapeutic Applications US 62/077,534 Abandoned
NIMH E-043-1997-2-CN-22 Methods for Expression and Purification of Immunotoxins CN DIV 2014106436989 Abandoned
NIAID E-214-2015-0-AU-05 Conformationally Specific Viral Immunogens AU National Stage 2013259548 Abandoned
NCI E-007-2014-0-FR-06 ALK ANTIBODIES, CONJUGATES, AND CHIMERIC ANTIGEN RECEPTORS, AND THEIR USE FR EP 14805427.3 Abandoned
NCI E-007-2014-0-DE-05 ALK ANTIBODIES, CONJUGATES, AND CHIMERIC ANTIGEN RECEPTORS, AND THEIR USE DE EP 14805427.3 Abandoned
NCI E-007-2014-0-EP-03 ALK ANTIBODIES, CONJUGATES, AND CHIMERIC ANTIGEN RECEPTORS, AND THEIR USE EP National Stage 14805427.3 Abandoned
NCI E-007-2014-0-GB-07 ALK ANTIBODIES, CONJUGATES, AND CHIMERIC ANTIGEN RECEPTORS, AND THEIR USE GB EP 14805427.3 Abandoned
NCI E-007-2014-0-PCT-02 ALK ANTIBODIES, CONJUGATES, AND CHIMERIC ANTIGEN RECEPTORS, AND THEIR USE PCT PCT PCT/US2014/064383 Expired
NCI E-261-2016-0-US-01 Compositions And Methods Of Diazeniumdiolate-based Prodrugs For Treating Cancer US 62/075,936 Abandoned
NCI E-750-2013-0-CA-04 Method for Subtyping Lymphoma Types by Means of Expression Profiling CA National Stage 2929826 Issued
NCI E-750-2013-0-AU-03 Method for Subtyping Lymphoma Types by Means of Expression Profiling AU National Stage 2014346788 Issued
NCI E-750-2013-0-EP-06 Methods for Subtyping Lymphoma Types by Means of Expression Profiling EP National Stage 14803288.1 Issued
NCI E-750-2013-0-FR-15 Methods for Subtyping Lymphoma Types by Means of Expression Profiling FR EP 14803288.1 Issued
NCI E-750-2013-0-DE-13 Methods for Subtyping Lymphoma Types by Means of Expression Profiling DE EP 14803288.1 Issued
NCI E-750-2013-0-CH-12 Methods for Subtyping Lymphoma Types by Means of Expression Profiling CH EP 14803288.1 Issued
NCI E-750-2013-0-GB-16 Methods for Subtyping Lymphoma Types by Means of Expression Profiling GB EP 14803288.1 Issued
NCI E-750-2013-0-ES-14 Methods for Subtyping Lymphoma Types by Means of Expression Profiling ES EP 14803288.1 Issued
NCI E-750-2013-0-IT-18 Methods for Subtyping Lymphoma Types by Means of Expression Profiling IT EP 14803288.1 Issued
NCI E-750-2013-0-IE-17 Methods for Subtyping Lymphoma Types by Means of Expression Profiling IE EP 14803288.1 Issued
NCI E-040-2012-0-RU-19 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen RU National Stage 2014144143 Issued
NCI E-271-2014-0-PCT-01 A New Class Of Stable Heptamethine Cyanine Fluorophores And Biomedical Applications Thereof PCT PCT PCT/US2014/064136 Expired
NCI E-750-2013-0-PCT-02 Methods for Subtyping Lymphoma Types by Means of Expression Profiling PCT PCT PCT/US2014/064161 Expired
NCI E-117-2011-0-ZA-21 Recombinant Immunotoxin Targeting Mesothelin ZA National Stage 2013/08270 Abandoned
NHLBI E-166-2014-0-US-01 T CELLS AND DENDRITIC CELLS FOR POLYOMAVIRUS THERAPY US 62/075,726 Abandoned
NIEHS E-080-2012-0-US-05 USES OF ANTAGONISTS OF HYALURONAN SIGNALING US National Stage 14/398,837 9717752 Issued PDF
NCATS E-072-2012-0-US-04 Modulators Of The Relaxin Receptor 1 US National Stage 14/398,830 9452973 Issued PDF
NCI E-044-2003-0-US-07 Compositions Comprising Nucleic Acids Encoding HIV-1 Reverse Transcriptase CTL Epitopes US DIV 14/531,540 Abandoned
NCI E-008-2014-2-CA-02 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same CA National Stage 2932424 Issued
NCI E-008-2014-2-SG-06 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same SG National Stage 11201604565W Issued
NCI E-008-2014-2-CN-03 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same CN National Stage 201480072437.4 Issued
NCI E-008-2014-2-JP-09 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same JP National Stage 2016-536812 Issued
NCI E-008-2014-2-US-08 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same US National Stage 15/101,583 10676528 Issued PDF
NCI E-008-2014-2-RU-05 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same RU National Stage 2016124670 Issued
NCI E-008-2014-2-FR-12 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same FR EP 14802259.3 Issued
NCI E-008-2014-2-DE-11 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same DE EP 14802259.3 Issued
NCI E-008-2014-2-EP-04 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same EP National Stage 14802259.3 Issued
NCI E-008-2014-2-GB-13 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same GB EP 14802259.3 Issued
NIAAA E-070-2012-0-GB-07 Derivatives of Docosahexaenoylethanolamide and Uses Thereof GB EP 13714787.2 Issued
NIAAA E-070-2012-0-DE-05 Derivatives of Docosahexaenoylethanolamide and Uses Thereof DE EP 13714787.2 Issued
NIAAA E-070-2012-0-FR-06 Derivatives of Docosahexaenoylethanolamide and Uses Thereof FR EP 13714787.2 Issued